Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. Click ...

Piper Sandler Virtual Novel Targets in Immunology Symposium February 12, 2026 5:00 PM ESTCompany ParticipantsPaul Burton - Senior VP ...

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, ...

This research topic focuses on the intricate interplay between the host immune response and potential therapeutic targets. Viral infections can exacerbate allergic conditions by dysregulating the ...

The human body is a dynamic place. Blood pumps, spinal fluid flows, oxygen comes in and carbon dioxide goes out. Deeper still, charged molecules pass through cell walls, quietly keeping the body's ...

Scientists uncover a new “recipe” that shows how exhausted T cells can be reprogrammed to regain their ability to attack tumors.

The field of bovine immunology has made significant strides in understanding the biology and function of T cells, which are crucial players in shaping ...

Bone health relies on a balance between osteoblasts (builders) and osteoclasts (recyclers). Peak bone mass occurs in early adulthood; deficiencies during this window amplify fracture risks later in ...

Executives at Amgen (NASDAQ:AMGN) outlined several upcoming clinical milestones and recent data updates across its ...

Emerging evidence supports the skin microbiome as a promising avenue for precision medicine in the treatment of dermatologic ...